Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02109016
Title A Study to Assess the Efficacy of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With FGFR1-driven Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Clovis Oncology, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU

Facility Status City State Zip Country Details
University of California, Los Angeles Los Angeles California 90095 United States Details
University of Colorado Aurora Colorado 80045 United States Details
Georgetown University Washington District of Columbia 20007 United States Details
Emory University Atlanta Georgia 30322 United States Details
Associates in Oncology and Hematology Rockville Maryland 20850 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
CHU Caen, Hôpital de la Côte de Nacre Caen 14033 France Details
CHRU Lille, Hôpital Albert Calmette Lille 59037 France Details
Hôpital Nord Marseille 13915 France Details
Institut Gustave-Roussy Villejuif 94805 France Details
Universität Duisburg-Essen Essen 45147 Germany Details
Hospital Grosshansdorf Grosshansdorf 22927 Germany Details
Pius Hospital Oldenburg Oldenburg 26121 Germany Details
Ospedale San Raffaele Milano 20132 Italy Details
Fondazione IRCCS Istituto Nazionale Tumori Milano 20133 Italy Details
AOU San Luigi Gonzaga Orbassano 10043 Italy Details
Ospedale S. Maria della Misericordia Perugia 06156 Italy Details
Hospital Universitari Vall d'Hebrón Barcelona Cataluña 8035 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field